Cargando…

Problems with the nested granularity of feature domains in bioinformatics: the eXtasy case

BACKGROUND: Data from biomedical domains often have an inherit hierarchical structure. As this structure is usually implicit, its existence can be overlooked by practitioners interested in constructing and evaluating predictive models from such data. Ignoring these constructs leads to potentially pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Popovic, Dusan, Sifrim, Alejandro, Davis, Jesse, Moreau, Yves, De Moor, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347616/
https://www.ncbi.nlm.nih.gov/pubmed/25734591
http://dx.doi.org/10.1186/1471-2105-16-S4-S2
Descripción
Sumario:BACKGROUND: Data from biomedical domains often have an inherit hierarchical structure. As this structure is usually implicit, its existence can be overlooked by practitioners interested in constructing and evaluating predictive models from such data. Ignoring these constructs leads to potentially problematic and the routinely unrecognized bias in the models and results. In this work, we discuss this bias in detail and propose a simple, sampling-based solution for it. Next, we explore its sources and extent on synthetic data. Finally, we demonstrate how the state-of-the-art variant prioritization framework, eXtasy, benefits from using the described approach in its Random forest-based core classification model. RESULTS AND CONCLUSIONS: The conducted simulations clearly indicate that the heterogeneous granularity of feature domains poses significant problems for both the standard Random forest classifier and a modification that relies on stratified bootstrapping. Conversely, using the proposed sampling scheme when training the classifier mitigates the described bias. Furthermore, when applied to the eXtasy data under a realistic class distribution scenario, a Random forest learned using the proposed sampling scheme displays much better precision that its standard version, without degrading recall. Moreover, the largest performance gains are achieved in the most important part of the operating range: the top of prioritized gene list.